PERSONAL INFORMATION
Name: WeiXiaoYu
Gender: Female
CONTACT INFORMATION
Email: wxy841101@163.com
Address: No. 439, Xuanhua Road, Yongchuan District, Chongqing
Phone: +86-15808056358
EDUCATION EXPERIENCE
1.2003.09 - 2008.07，Bachelor's degree , Chongqing Medical University.
2.2008.09- 2011.07，Master's degree , Chongqing Medical University.
3.2014.09-2018.12，Ph.degree.Chongqing Medical University.
WORKING EXPERIENCE
1.2011.07-2017.03 ,Resident, Department of Infectious Diseases, Yongchuan Hospital Affiliated to Chongqing Medical University.
2. 2017.04- 2021.03, Lecturer, Attending Physician, Department of Infectious Diseases, Yongchuan Hospital Affiliated to Chongqing Medical University.
3.2021.04-2021.11, Deputy Chief Physician, Department of Infectious Diseases, Yongchuan Hospital Affiliated to Chongqing Medical University.
4.2021.12-1 2022.09, Associate Professor of the Fifth Clinical College, Deputy Director of Infectious Diseases Department, Yongchuan Hospital Affiliated to Chongqing Medical University.
5.2022.10-2023.02,Temporary Head of Quality Management Department (Performance Appraisal Office) of Yongchuan Hospital Affiliated to Chongqing Medical University.
6.2023.03 to present, the deputy section chief of the Quality Management Department (Performance Appraisal Office) of Yongchuan Hospital Affiliated to Chongqing Medical University.
RESEARCH INTERESTS
Professor Wei has devoted to the research of infectious diseases, mainly in the fields of AIDS, liver fibrosis and liver cancer.She received funding for 4 projects.
She has been in charge of the research of blood purification technology in the clinical treatment of AIDS patients with opportunistic infection (Ycstc, 2015nc5029), the research of serological IgM and IgG detection in clinical Novel Coronavirus, the research of anti-fibrosis mechanism of ginsenoside Rg1 (YJJC201704), and the establishment of pneumonia disease progress and prognosis model in Novel Coronavirus.
HONOUR & AWARDS
The title of March Eighth Red Flag Bearer in Yongchuan District，2020
The title of "Advanced Individual" in fighting novel coronavirus pneumonia，2020
The title of "Women's Meritorious Model" in Chongqing，2020
PUBLICATIONS
1.Jie Hu 1,Xiao-Yu Wei 2, Jin Xiang 1,Pai Peng 1, Feng-Li Xu 1, Kang Wu 1, Fei-Yang Luo 3,Ai-Shun Jin³,Liang Fang ²,Bei-Zhong Liu ², Kai Wang 1, Ni Tang 1, Ai-Long Huang 1.Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera.Genes Dis. 2022 Sep;9(5):1290-1300.(IF:7.24).
2.Xiao-Yu Wei 1, Jing Ding 1,Wen-Guang Tian 1, Yi-Chuan Yu 2.IcroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review .J Int Med Res.2020Aug ;48(8) :300060520941634 .(IF:1.3).
3.Jiajun Lia, Xiaoyu Weib, Wenguang Tianb, Jingbo Zouc, Yue Wanga, Wei Xuea, Qing Xiaoa, and Wenxiang Huanga,Clinical features of discharged COVID-19 patients with an extended SARS-CoV-2 RNA positive signal in respiratory samples.Virus Res. 2020 Sep; 286: 198047.(IF:2.3).
4.Xiao-Yu Wei 1, Ding Jing 1, Bei Jia 2, Qing Li 2, Xia-Qia Zhou 1, Ming-Feng Gong 1, Jing-Bo Zou 3, Qiang Zhang 2, Wen-Xiang Huang 4, Wen-Guang Tian 1.Characteristics of in peripheral blood of 70 hospitalized patients and 8 diarrhea patients with COVID-19.Int J Med Sci. 2020 May 17;17(9):1142-1146.(IF:3.738).
5.Xiaoyu Wei 1, Yatang Chen 2, Wenxiang Huang 2.Ginsenoside Rg1 ameliorates liver fibrosis via suppressing epithelial to mesenchymal transition and reactive oxygen species production in vitro and in vivo.Biofactors. 2018 May 15.(IF:3.598).
